DNA EBITDA Margin

Ginkgo Bioworks Holdings Inc Class · EBITDA Margin

DNA logo

DNA EBITDA Margin

Latest reported-216.35%
DNA EBITDA Margin (-196.85% → -216.35%)
High-resolution chart · PNG

DNA ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Ginkgo Bioworks Holdings Inc Class EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-149.6342%
-213.349%
-326.6163%
-435.1507%
-575.6724%
-141.6505%
-196.8459%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.